LLY

3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals

By Larry Ramer, InvestorPlace Contributor
The demand for obesity drugs is intense and is likely to only greatly increase going forward, since over 40% of Americans were obese in 2020. 

Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher

By Muslim Farooque, InvestorPlace Contributor
With their seamless blend of promise and innovation, these biotech stocks to buy offer a strategic gateway to fortify your portfolio.

David vs. Goliath: 3 Stocks Poised to Challenge the ‘Magnificent 7′

By Alex Sirois, InvestorPlace Contributor
These three stocks are legitimate challengers to the dominance of the Magnificent 7 stocks as we move toward the end of 2023.

Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend

By John Blankenhorn, InvestorPlace Contributor
Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today.

The 7 Most Hated Stocks by Institutional Traders

By Josh Enomoto, InvestorPlace Contributor
Discover the surprising stocks institutional traders are selling, and find out what their moves could mean for your portfolio's future.

Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold

By Joel Baglole, InvestorPlace Contributor
Excitement is building around the potential health and financial benefits of these new weight-loss medications.

3 Nasdaq Stocks to Sell in September Before They Crash & Burn

By Matthew Farley, InvestorPlace Contributor
These Nasdaq stocks to sell are all risky plays with uncertain futures. It's a good idea to sell or trim your positions in them now.

7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth

By Louis Navellier and the InvestorPlace Research Staff
Pharma stocks can be a great investment, particularly if they have solid performance, revenue growth and a positive outlook.

7 A-Rated Blue-Chip Stocks to Secure Your Financial Future

By Louis Navellier and the InvestorPlace Research Staff
Blue-chip stocks earn that moniker because they're doing something right – they have a track record of success that investors find appealing.

7 Stocks Sitting At 52-Week Highs Right Now

By Joel Baglole, InvestorPlace Contributor
While the broader market has taken a breather in August, it hasn't stopped a select number of stocks from continuing their march higher. Propelled by strong earnings and upbeat guidance, the shares of several leading companies are now at their highest level in a year.

3 Biotech Stocks That Wall Street Analysts Can’t Get Enough Of

By Larry Ramer, InvestorPlace Contributor
Worries about biotech stocks are way overdone, so the sector should make a big comeback in the coming months. 

The 3 Most Promising Pharma Stocks to Own Now

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
A pillar to economic growth in a defensive area, these promising pharma stocks are set to rise and give investors one bullish ride.

The 3 Blue-Chip Stocks Every Investor Needs to Own Today

By Rick Orford, InvestorPlace Contributor
These three blue-chip stocks are all industry giants in their respective sectors — and offer future growth and stability.

Want to Get Rich? 3 Game-Changing Growth Stocks to Buy Right Now

By Joel Baglole, InvestorPlace Contributor
Look to these growth stocks to buy to provide huge growth moving forward as they each have strong catalysts and bullish long-term outlooks.

7 A-Rated Growth Stocks to Grab Up Now

By Louis Navellier and the InvestorPlace Research Staff
Investing in A-rated growth stocks is one of the best tools you have to build your portfolio and set it up for long-time growth.

7 A-Rated Biotech Stocks for Your August Buy List

By Louis Navellier and the InvestorPlace Research Staff
Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge.

3 Growth Stocks to Sell in August Before They Crash and Burn

By Joel Baglole, InvestorPlace Contributor
Stock markets are enduring turmoil this August. Since the beginning of the month, the benchmark S&P 500 index has declined 2%. The downturn comes amid…

Eli Lilly (LLY) Stock Just Reached a New All-Time High

By Josh Enomoto, InvestorPlace Contributor
Pharma giant Eli Lilly saw LLY stock reach record heights as the company posted strong Q2 results, undergirded by a key diabetes drug.

7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes

By Joel Baglole, InvestorPlace Contributor
Healthcare continues to be a major industry and economic driver around the world. According to the American Medical Association, spending on healthcare in the U.S. totals more than $4 trillion each year, which works out to nearly $13,000 per person.
Load More